InvestorsHub Logo

gemmill

03/04/14 12:43 PM

#9430 RE: zoriden #9428

Wow Zoriden, Excellent NEWS!!! THANKS! Did they give any indication on when this would officially be made public?

erostratus

03/04/14 12:49 PM

#9432 RE: zoriden #9428

Awesome! Thanks for that confirmation Z. The immunogenic effects of Immunopulse will ensure maximized applicability of anti-pd-1s. 100% efficacy on all subjects in preclinical study. Even a fraction of that result will be groundbreaking.
I mean forget pre-clinical. Big Pharma has already proven that checkpoint inhibitors are immunotherapy powerhouses. Add on IL-12 for maximum applicability and you have money in the bank.
This sh#t is revolutionary dudes!
Load up before PR announcements send us flying!

lasers

03/04/14 12:56 PM

#9435 RE: zoriden #9428

Yes addition of PD-1/PDL-1 to Melanoma Phase2B is super huge. IMO $ONCS Phase2B Melanoma with addition of PD-1/PDL-1 to PIL-12+EP may very well qualify $ONCS Phase2B Melanoma as a Pivotal trial from which continuing super results would enable the FDA to award a Commercial BLA license to $ONCS Melanoma. Just saying, not for certain as it will be up to the FDA . At the very least super results for $ONCS Phase2B could mean a much smaller and less costly Phase3.

trading.jeff

03/04/14 1:51 PM

#9457 RE: zoriden #9428

Nice DD, Z. Could $ONCS hit a buck TODAY??

poolguy1

03/04/14 3:20 PM

#9500 RE: zoriden #9428

Zoriden, I was taken aback by today's sudden rise in share price without any new developments since monday's investor wall street conference, what is happening here! Of course I was searching through google to find relevant articles for ONCS but nothing appeared, at least nothing important and material that would justify a CURRENT VALUATION OF $3 has appeared in any official PR. Please tell me is this the beginning of something good, what are the highlights of ONCS in 2014, and immediately whether we are going to see some great things?